Miro Biotech

Business

Miro Biotech Announces Global Availability of High-Purity Research Peptide Catalog

Bangalore (Karnataka) [India], April 15, 2026. Miro Biotech today announced the global availability of its research-grade peptide catalog, extending HPLC-verified compounds to individual researchers, laboratories, and academic institutions across India, North America, Latin America, Europe, Africa, Asia-Pacific, and the Middle East. Demand for high-purity research peptides has accelerated across academic and industrial research groups, driven by expanding in-vitro investigation of…